Skip to main content

Posts

Atherosclerosis

Atherosclerosis Other names Arteriosclerotic vascular disease (ASVD) Illustration depicting atherosclerosis in a coronary artery Specialty Cardiology, vascular surgery, cardiothoracic surgery, interventional radiology Symptoms None Complications Coronary artery disease, stroke, peripheral artery disease, kidney problems, heart disease Usual onset Youth (worsens with age) Causes Accumulation of saturated fats, smoking, high blood pressure, and diabetes Risk factors High blood pressure, diabetes, smoking, obesity, family history, unhealthy diet (notably trans fat and hydrogenated oils), chronic Vitamin C deficiency Prevention Healthy diet, exercise, not smoking, maintaining a normal weight Medication Statins, blood pressure medication, aspirin Frequency ≈100% (>65 years old) Atherosclerosis  is a pattern of the disease arteriosclerosis, characterized by development of abno...

Iron poiosoning and their antidote Deferoxamine

Deferoxamine Skeletal formula and spacefill model of deferoxamine Clinical data Trade names Desferal Other names desferrioxamine B, desferoxamine B, DFO-B, DFB ,N'-[5-(Acetyl-hydroxy-amino)pentyl]-N-[5-[3-(5-aminopentyl-hydroxy-carbamoyl) propanoylamino]pentyl]-N-hydroxy-butane diamide AHFS/Drugs.com Monograph Routes of administration intramuscular intravenous subcutaneous Pharmacokinetic data Elimination  half-life 6 hours Chemical and physical data Formula C 25 H 48 N 6 O 8 Molar mass 560.693  g·mol −1 3D model (JSmol) Interactive image SMILES InChI Deferoxamine  ( DFOA ), also known as  desferrioxamine  and sold under the brand name  Desferal , is a medication that binds iron and aluminium. It is specifically used in iron overdose, hemochromatosis either due to multiple blood transfusions or an underlying genetic condition, and aluminium toxicity in people on dialysis. It is used ...